New obesity drug XW003 takes on semaglutide in Head-to-Head trial
Disease control
Ongoing
This study tests whether a new drug called XW003 works better than the existing drug semaglutide for weight loss in Chinese adults with obesity. About 163 participants with a BMI of 30 or higher will receive either drug, and researchers will measure changes in body weight, waist …
Phase: PHASE2 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC